Synergistic combination to overcome immunotherapy resistance in MSS-type CRC. Ferroptosis inducers directly kill cells and release DAMPs (e.g., HMGB1) to activate anti-tumor immunity. The gene discussed is HMGB1; the disease is colorectal carcinoma.